GAAP EPS

Related by string. * Gaap . GAAPs : Non GAAP Financial . Non GAAP net . Non GAAP Measures . Non GAAP Adjustments . Non GAAP diluted . RECONCILIATION OF NON GAAP . Non GAAP Reconciliation . Non GAAP Reconciliations / EPD . EPs . ep . eps . Ep . Eps . ePS : adjusted EPS . Adjusted EPS . FY# EPS guidance . reaffirms FY# EPS . Reaffirms FY# EPS . EPS estimate . eg EPS Profitability * Non GAAP EPS *

Related by context. All words. (Click for frequent words.) 81 Non GAAP EPS 80 diluted EPS 78 adjusted EPS 76 EPS 75 pro forma EPS 71 Adjusted EPS 69 proforma EPS 69 normalized EPS 69 Diluted EPS 69 Sees FY# EPS 68 Pro forma EPS 67 normalized FFO 67 EPADS 67 FY# revs 67 adj EPS 67 FY# EPS 67 Fully diluted EPS 66 Non GAAP diluted 66 Normalized EPS 65 FY# EPS guidance 65 EPS Guidance 65 Adjusted Diluted EPS 65 2Q EPS 65 FQ2 EPS 64 F#Q# EPS 64 FQ1 EPS 64 Raises FY# EPS 64 Pro Forma EPS 64 Sees Q4 64 FQ3 EPS 64 FFO Per Share 63 Q3 revs 63 netincome 63 FQ4 EPS 63 Pro forma diluted 63 #Q# EPS 63 #.#-#.# excluding 63 DEPS 63 CY# EPS 63 .#/share 63 FQ1 63 #.# perdiluted 62 Q# revs 62 sees FY# EPS 62 earnings pershare 62 Fully diluted earnings 62 Q3 EPS 62 Projected FFO 62 Q1 EPS 62 excluding nonrecurring items 62 Quick Facts2 61 #.#-#.# bln [007] 61 Diluted earnings 61 #.#/diluted share 61 Sees Q3 61 Sees Q2 61 Q4 revs 61 Lifts FY# EPS 61 Adjusted diluted 61 #.#-#.# vs 61 diluted share 61 EPS estimate 61 Guides Q3 61 Core FFO 61 Reaffirms FY# EPS 61 fully diluted 60 FFO 60 F1Q 60 GAAP Diluted EPS 60 Normalized EBITDA 60 Non GAAP net 60 Zacks Consensus 60 Q2 EPS 60 Non GAAP Diluted EPS 60 Adjusted Pro Forma 60 Q2 revs 60 #.#-#.# usd [002] 60 non GAAP 60 Provides FY# EPS 60 FY# EPS estimate 60 F4Q 60 Earnings Per Share 60 #E EPS 60 Backs FY# 60 Earnings Guidance 60 EPS ests 60 Maintains FY# 60 Matches Estimate 60 Revises FY# EPS 60 FQ3 60 Q1 revs 59 Carrols Restaurant 59 Q4 EPS 59 Backs FY# EPS 59 FY# Guidance 59 Sees Q1 59 Guides Q4 59 Q1 FY# EPS 59 Cuts FY# EPS 59 diluted weighted 59 diluted EPADS 59 F3Q 59 Lifts FY# Revenue 59 Raises FY# 59 Pro forma EBITDA 59 Guides Q1 59 Sees FY# adj EPS 59 Remains Inline 59 Updates FY# EPS 59 Forecast Quick Facts 59 F#Q# revenues 59 Backs FY# Revenue 59 sees FY# revs 59 DAC unlock 59 Sees Q# 59 Guidance Quick Facts 59 adjusted EBITDA 59 Adjusted Earnings 59 Q#/FY# 59 items affecting comparability 58 Guides Q2 58 pershare 58 Tightens FY# 58 Affirms FY# 58 Pro forma Adjusted EBITDA 58 Revises FY# 58 non gaap 58 Qtr Qtr 58 F1Q EPS 58 Normalized FFO 58 Narrows Quick Facts 58 Below Consensus 58 Sees FY# revs 58 Lowers FY# EPS 58 View Quick Facts 58 per dilutedshare 58 Fully diluted 58 Exceptional Items 58 fiscal# 58 Reiterates Guidance 58 EBITDAO 58 F#Q# Earnings 58 '#E EPS 58 FFO FFO 58 operating income1 58 Items Affecting Comparability 58 reaffirms FY# revs 58 Diluted Share 58 adjusted Ebitda 58 excluding nonrecurring 58 #.#-#.# mln usd 58 EPS Excl 58 pro forma 58 Normalised earnings 58 Sees FY 58 Exceeds Guidance 58 FY# EPS Outlook 58 Non GAAP adjusted EBITDA 58 Net Income 57 Lowers FY# 57 Diluted Earnings Per Share 57 Boosts FY# 57 nonGAAP 57 pro forma adjusted EBITDA 57 #.#/share [002] 57 Reaffirms FY# 57 F2Q 57 Zacks Estimate 57 FQ4 57 Earnings Per Diluted 57 Fully Diluted EPS 57 Consolidated EBITDAR 57 Q4 adj EPS 57 Guides FY# 57 Loss Per Share 57 QUALCOMM pro forma 57 SEK#M 57 Reaffirms Full 57 Diluted EPS Guidance 57 H1 FY# [001] 57 Lifts FY# 57 Misses Consensus 57 lowers FY# EPS 57 modestly accretive 57 Q2 adj 57 Above Consensus 57 Consolidated Adjusted EBITDA 57 Guides FY# EPS 57 Individual Annuities segment 57 reports Q4 adj 57 operatingincome 57 continuingoperations 57 4Q FY# 57 Zacks Consensus Estimates 57 earnings 56 #.#/shr [002] 56 vs #.#m bt 56 CFFO 56 Forward Looking Guidance 56 Ps.#.# [006] 56 adopting SFAS #R 56 Reiterates FY# EPS 56 Boosts FY# EPS 56 Q2 FY# [001] 56 Projected FFO per 56 earnigns 56 Pro forma net 56 ests 56 Lifts FY# Earnings 56 Slashes FY# 56 modestly dilutive 56 Matches Consensus 56 #-# mln sfr 56 Operational EBITDA 56 Earnings 56 Reiterates FY# 56 Free Cash Flow 56 Cuts FY# 56 EPS Rises 56 Lifts FY# Outlook 56 F2Q EPS 56 GAAP 56 per share1 56 Hovnanian trims 56 FFOPS 56 Normalised headline 56 = Diluted [019] 56 Reaffirms Guidance 56 BVPS 56 AFFO 56 #.#-#.# mln vs. [002] 56 FY# NPAT 56 EPS GUIDANCE 55 Adjusted FFO 55 Tops Estimate 55 Fourth Quarter Earnings Per 55 Q4 Adj 55 FQ2 55 Unlevered Cash Flow 55 #,# c [002] 55 BUSINESS OUTLOOK 55 EBITD 55 pro forma EBITDA 55 Tops Consensus 55 Guidance Guidance 55 Oxy ER 55 #.#-#.# mln vs. [001] 55 PVSW 55 Revises FY# Outlook 55 F4Q EPS 55 Adjusted Earnings Per 55 Guides Above 55 FFOM 55 invoiced shipments 55 #.#-#.# bln eur [003] 55 Q4 FY# EPS 55 Diluted EPS Diluted 55 F#Q# 55 #.#-#.# vs. 55 F#Q# EPS ahead 55 option expensing 55 Including discontinued operations 55 #.#-#.# bln [002] 55 FNDT 55 EDITDA 55 FY# EPS View 55 mildly dilutive 55 reports Q3 adj 55 Non GAAP Adjusted EBITDA 55 Qualcomm Strategic Initiatives 55 EBDDT 55 Reaffirms FY# Revenue 55 EPADS estimates 55 share assuming dilution 55 Lowers FY# Outlook 54 Consensus Estimate 54 Backs FY# Earnings 54 nonroutine income 54 EUR#M EUR#M 54 Zacks Consensus Estimate 54 Non GAAP 54 Adjusted Basis 54 EPADR 54 Co reaffirms FY# 54 SEK -#.# -#.# [001] 54 non recurring 54 revenue USD #.#bln 54 Outlook Quick Facts 54 Beats Estimate 54 #.#-#.# mln [001] 54 FY# FY# EPS 54 EPADS estimate 54 FAS CAS pension 54 Lowers Guidance 54 CHF#.#B 54 prioryear 54 NASDAQ PRXL 54 #.#/ADR 54 Lowers Q4 54 excluding goodwill impairment 54 Below Estimates 54 Backs FY# Forecast 54 Guidance Raised 54 REBIT 54 Net Loss Per 54 Increases Guidance 54 NuVasive NASDAQ NUVA 54 Meets Estimates 54 revises FY# 54 normalized EBIT 54 No. #R 54 Tops Estimate Update 54 NASDAQ SMCI 54 Guides Inline 54 #-# MMcfe d 54 3Q 4Q 54 Guides Q# 54 Revises Full 54 Recurring FFO 54 Non IFRS 54 Income Per Share 54 OPENWAVE SYSTEMS 54 Raises Guidance 54 Consolidated Adjusted OIBDA 54 Assuming Dilution 54 Adjusted EBT 54 Q4 FY# [001] 54 Sees FY# 54 Net Loss 54 FAS #R 54 Technology NASDAQ WATG 54 #.#per diluted 54 Fy# 54 TEUR -# 54 Backs FY# Outlook 54 Fiscal Quarter Earnings 54 Misses Views 53 Narrows FY# EPS 53 NASDAQ XRAY 53 SCHEDULED TO PREMIERE 53 Allscripts Healthcare Solution MDRX 53 DiaMed acquisition 53 adjusted EBITDAR 53 Revises Q4 53 dacetuzumab collaboration 53 ESTIMATE FOR 53 CY# EPS estimate 53 adjusted HEPS 53 Consolidated OIBDA 53 Reaffirms Outlook 53 Revises Third Quarter 53 = Earnings [013] 53 FY#Q# 53 Guides Below 53 nonoperating items 53 Diluted FFO 53 Rs #.# lacs [002] 53 Noninterest Expense Noninterest expense 53 Opns 53 gross margin 53 EBITA 53 Q1 Adj 53 PDP MLR 53 thefourth quarter 53 Non GAAP Earnings Per 53 IVGN 53 Q4 Profit Soars 53 Revises FY# Guidance 53 adjusted1 net 53 Non GAAP Basis 53 Concur Technologies Inc CNQR 53 Sees FY# revenues 53 USD #.#bln [001] 53 antidilutive 53 Fully Diluted Earnings Per 53 #.#/ADR increasing 53 Rises Beats Estimates 53 CNMD 53 diluted ADS 53 per MCFE 53 GBP#.#M [002] 53 SS NOI 53 F3Q EPS 53 DEPS guidance 53 3Q FY# 53 financialperformance 53 #.#-#.# mln [004] 53 From Continuing Operations 53 EPS accretion 53 Guidance Range 53 USD#.#m USD#.# [002] 53 Revises Guidance 53 excluding exceptionals 53 #e EPS 53 PER DILUTED SHARE 53 invoiced shipment 53 USD#.#m USD#.# per [002] 53 BioMarin Genzyme LLC 53 consolidated OIBDA 53 Omnova Solutions NYSE OMN 53 Cont Ops 53 Q4 Profit Slips 53 Sees 3Q 53 Deckers Outdoor 53 SFAS# R 53 Pretax Income 53 FIFO EBITDA 53 reaffirms FY# 53 Q3 FY'# 53 Informatica INFA 53 #.#-#.# bln dkr [002] 53 SEK -#.# [002] 53 Guidance Disappoints 53 Adjusted EBITDA excludes 53 Nordson Corporation Declares 53 Revises Fiscal 53 #.#/sh 53 Recurring EBITDA 53 Ups Guidance 53 normalized FFO guidance 53 reaffirms FY# guidance 53 guides FY# EPS 53 EBITANCE 53 Narrows Guidance 53 noninterest expense totaled 53 non GAAP1 53 Waste Connections WCN 53 Reaffirms Fiscal 53 FFO Declines 53 FY# [001] 53 Dividend Quick Facts 53 Amkor Technology NASDAQ AMKR 53 Excluding goodwill impairment 53 EBITDAS 53 Above Estimates 53 Adjusted OIBDA 53 .# Per Share 53 Varian Semi 53 Huipu 53 Changyou.com Limited NASDAQ CYOU 52 Before Unusual Items 52 Susquehanna Bancshares NASDAQ SUSQ 52 NHWK 52 Beats Zacks 52 adjusted EBITA 52 Dress Barn NASDAQ DBRN 52 consensus estimate 52 China Biotics NASDAQ CHBT 52 Diluted HEPS 52 Updates Guidance 52 No. #R SFAS 52 Tibco TIBX 52 COMPUTATION 52 Q4 F# 52 PRXL 52 Vishay Intertechnology VSH 52 EBITDA 52 Earning Per Share 52 adjusted EBITDAS 52 Outlook Disappoints 52 netsales 52 #.#-# mln [001] 52 amortization expense 52 TEB adjustment 52 NOPAT 52 fiscal year# 52 Non GAAP Disclosures 52 Tikcro Technologies Reports 52 #QF# 52 RRGB 52 Goodwill Impairment Charge 52 Second Quarter Highlights 52 EARNINGS IN RETROSPECT 52 Adjusted FIFO EBITDA 52 Significant Items 52 Adjusted EBITDAS 52 GUIDANCE 52 NOL utilization 52 normalized EBITDA 52 SYPR 52 Comparable FFO 52 Guidance Reaffirmed 52 #.#x FY# [002] 52 Loss Narrowed 52 Steiner Leisure NASDAQ STNR 52 AMAG Pharmaceuticals AMAG 52 OIIM 52 #.#-#.# bln eur [005] 52 EARNINGS GUIDANCE 52 Misses View 52 Reiterates Fiscal 52 DKK#.# [003] 52 ESIO 52 contingently convertible securities 52 Reaffirms FY# Outlook 52 Lifts FY# Guidance 52 ascompared 52 EUR -#.# [001] 52 NON GAAP 52 Fully Taxed EPS 52 LWSN 52 Selected GAAP Measures 52 exclude noncash 52 SEK#.#bn [002] 52 EUR #,# Mio 52 FY# Quick Facts 52 EBITDAA 52 Q1 adj 52 noncash amortization 52 fuel CASM 52 EBIT 52 Cymer NASDAQ CYMI 52 #.#x #.#x [003] 52 -By DON HUNTER 52 Littelfuse NASDAQ LFUS 52 Luminex NASDAQ LMNX 52 Q2 FY'# 52 FASB #R 52 OP Unit 52 Fourth Quarter Fiscal 52 = Diluted [008] 52 Misses Q2 52 Adjusted Ebitda 52 GAAP Generally Accepted 52 nine monthsended 52 Pro Forma Adjusted 52 NPAT 52 Electro Scientific 52 - - Diluted [005] 52 #.#x FY#E [002] 52 = DilPIC#F 52 WW Grainger GWW 52 = Diluted earningsAll Dogfighters 52 = Diluted [033] 52 = Adjusted [008] 52 n#.# [002] 52 SYMM 52 intangible impairment 52 ULGX 52 Consolidated EBITDA Margin 52 #.#-#.# bln [005] 52 aftertax gain 52 Earnings Announcement Date 52 Regeneron Pharma 52 = Diluted espokesman Dan Jiron 52 ATCF 52 Widens Quick Facts 52 Earnings Preview EBay 52 Pro forma FFO 52 Fourth Quarter Dividend 52 - - Diluted [008] 52 ESCO Technologies 52 EPS accretive 52 reaffirms FY# EPS 52 noncash goodwill impairment 52 Non GAAP Adjusted 52 Normalized Earnings 52 CHF#M 52 Adjusted pro forma 52 retrospectively adjusted 52 CORE EARNINGS PER SHARE 52 SEK#.# [002] 52 Spreadtrum Comms 52 Realized Earnings 52 Plexus NASDAQ PLXS 52 IDTI 52 EPS Beats Estimate 52 Earnings Preview Bristol Myers 52 SFAS #R 52 Tessera Technologies NASDAQ TSRA 52 = Diluted [014] 52 Reaffirms Earnings 52 Projected Release Date 52 LIFO inventory adjustments 52 Q2 Adj 52 Earnings Loss Per 52 PV module shipments 52 diluted FAD 52 EBTIDA 52 Unfavourable Changes 52 = Adjusted [002] 52 Rs.#.# crores [006] 52 = Diluted earniSivasubramaniam 52 Rs4 #cr 52 Diluted Earnings Loss Per 52 LIFO adjustment 52 Common Share Dividend 52 Cents Vs 52 Molex NASDAQ MOLX 52 Dionex NASDAQ DNEX 52 BRKS 52 Noninterest expense totaled 52 DILUTED SHARE 52 AND ADJUSTED DILUTED EARNINGS 52 USD#.#m USD#.# per [001] 51 Pepsi Bottling PBG 51 Raises PT 51 CHF#.# billion [002] 51 -Bond Index Etf 51 Q1 FY# [002] 51 = Diluted [017] 51 #.Net 51 Wireline adjusted EBITDA 51 diluted HEPS 51 Q3 Profit Slips 51 FTI Consulting NYSE FCN 51 Tops Ests 51 ended September# 51 EBITA margin 51 RDWR 51 adjusted1 51 Operations FFO 51 CIENA CIEN 51 Continuing Operations 51 totaled USD#.#m 51 Preliminary Second Quarter 51 TWACS NG software 51 FY# adj 51 ¥ #.#B [001] 51 Diluted EPS attributable 51 Per Diluted 51 DKK#.# [001] 51 LIFO provision 51 Comtech Telecom 51 Gross Addition CPGA 51 RF Micro Device 51 Weighted average diluted 51 Valspar VAL 51 CGNX 51 = Diluted [015] 51 Ebita margin 51 BioCryst Pharmaceuticals NASDAQ BCRX 51 Lifts Quarterly Dividend 51 Pro Forma EBITDA 51 Saehan Bancorp Reports 51 Adjusted Gross Profit 51 Surface Specialties acquisition 51 FAS# R 51 -dnj.com 51 Modified EBITDA 51 HK#.# cents [001] 51 Preliminary Third Quarter 51 revs Reports 51 HEPS 51 Diluted Earnings 51 LivePerson NASDAQ LPSN 51 Canaccord Genuity Maintains Hold 51 Linear Technology NASDAQ LLTC 51 Pro Forma Condensed Consolidated 51 EARNINGS LOSS PER SHARE 51 FFO payout ratio 51 Updates Fourth Quarter 51 Exceed Guidance 51 Restruct 51 Y#.# prft Y#.# prft [002] 51 Per Fully Diluted 51 ENZN 51 Misses Expectations 51 Declares Dividend Update 51 CRXX 51 Reaffirms Second Quarter 51 Loss Reduces 51 Misses Q3 51 MLNX 51 PLXT 51 Conceptus NASDAQ CPTS 51 MYGN 51 thirteen analysts polled 51 Lifts FY# View 51 - - Diluted [007] 51 Constant Currency 51 Reaffirms Fourth Quarter 51 Backs FY# Adj 51 Downstream CCS 51 Guides FY# Earnings 51 Fiscal 1Q Profit 51 Adjusted EBITDA 51 ZHONGPIN INC. 51 Ag Eq oz 51 = Diluted [029] 51 Henry Schein NASDAQ HSIC 51 Q1 FY'# 51 SEK -#.# [001] 51 1/share 51 Loss Shrinks 51 Q3 FY# [001] 51 Excluding Unusual Items 51 Penwest Pharmaceuticals Co 51 Quarter Earnings 51 temporary impairments OTTI 51 Special Cash Dividend 51 Dillards Inc 51 Statutory Accounts 51 Fully diluted weighted 51 Non GAAP Operating Margin 51 CKSW 51 FINANCIAL HIGHLIGHTS IN THOUSANDS 51 '#E 51 ADTN 51 NewsBite Downgrade Puts Pressure 51 CHF4 51 - - Diluted [003] 51 VCA Antech NASDAQ WOOF 51 Urban Outfitters NASDAQ URBN 51 COMMON SHARES OUTSTANDING Basic 51 priceline.com NASDAQ PCLN 51 - - Joanne Kempinger Demski 51 = Earnings [026] 51 Trustmark NASDAQ TRMK 51 Irvine Sensors Releases 51 Higher Expenses 51 Diebold NYSE DBD 51 Reaffirms FY# Earnings 51 NAREIT FFO 51 diluted 51 Interest Expense Interest expense 51 Q4 Profit Decreases 51 amortization OIBDA 51 Compensation Expense 51 Dynamex Announces 51 Q4 51 COHU 51 LOSS PER COMMON SHARE 51 Q2 FY 51 HealthStream Learning 51 Becton Dickinson NYSE BDX 51 NET INCOME TO NON 51 fullyear 51 #.#/Share [002] 51 Items excluded 51 Q1 F# 51 Revises Q3 51 Vyvx Advertising Distribution 51 Three Month Periods 51 SSNOI 51 income1 51 FY# EPS Forecast 51 EUR#.# EUR#.# [002] 51 CROCS NASDAQ CROX 51 SIGMA DESIGNS 51 increaseof 51 typically exclude special 51 Contingent Convertible Senior Subordinated 51 Raises Full 51 NET INCOME PER COMMON 51 minimally dilutive 51 FAS#R 51 = Diluted [022] 51 adjusted EBIT 51 Postpay ARPU 51 Select Comfort NASDAQ SCSS 51 ROFE 51 Tops Estimates Update 51 LIFO accounting 51 heps 51 PMPS brand 51 Beats Estimate Update 51 inventories revalued 51 #,#,# =Rayola Dougher senior 51 = Diluted [007] 51 Maintenance Capital Expenditures 51 DSGX 51 NOL carryforwards 51 Net Loss Attributable 51 = Diluted earnings [007] 51 NASDAQ CTSH 51 Q4 adj 51 Reconciling Items 51 Medicare Advantage MLR 51 Motorhome Resorts Segment 51 eResearchTechnology NASDAQ ERES 51 BJ Restaurants BJRI 50 Concur Technologies Inc 50 Volterra Semi 50 Hanger Orthopedic 50 Confirms Guidance 50 income teb 50 WESTWOOD ONE INC. SUPPLEMENTAL 50 = DKey4Women 50 Non GAAP1 50 Prepaid churn 50 CRIC shareholders 50 YTD# 50 Restructuring Charge 50 Convertible Subordinated Debt 50 excluding reimbursables 50 Schedules Third Quarter Fiscal 50 Q3 Adj 50 GLCH 50 profit beia 50 Adjusted Diluted Earnings 50 Fourth Quarter Earnings Preview 50 Operating Cash Flow 50 Items affecting comparability 50 mainline CASM 50 EBITDA1 50 Items impacting comparability 50 Trims Outlook 50 EBITDAF 50 Distributable Earnings 50 Sees 4Q 50 Fully Diluted Earnings 50 Q4 FY# [002] 50 wafer shipments 50 Upside Purchased 50 Adjusted Non GAAP 50 TIBX 50 BioMimetic Therapeutics NASDAQ BMTI 50 Million Stock Buyback 50 Second Quarter Earnings Per 50 HB Fuller NYSE FUL 50 ended December# 50 NET EARNINGS PER SHARE 50 Volterra Semiconductor 50 Q3 adj 50 Somaxon Pharma 50 Altera NASDAQ ALTR 50 ADJUSTED FOR 50 EARNINGS PER SHARE DILUTED 50 - Net income 50 standardized distributable cash 50 PWOD 50 WYNDHAM WORLDWIDE 50 Oncothyreon Inc 50 Nxstage Medical 50 Second Quarter Dividend 50 FY #E [001] 50 Q4 FY 50 #.#c #.#c [006] 50 Reaffirms FY 50 Third Quarter Dividend 50 Solectron pro forma 50 Normalized Funds 50 narrows Quick Facts 50 #.# = Diluted [003] 50 Revised Guidance 50 millioncompared 50 DILUTED EPS 50 income allocable 50 UACL 50 QUARTER ENDED JUNE 50 #-#.# mln eur 50 CY#E [001] 50 Quarter Results 50 #,# =Jaegle 50 = Diluted earnings [009] 50 COMPANY SYMBOL QTR EPS 50 Momenta Pharmaceuticals NASDAQ MNTA 50 Kla Tencor 50 = Earnings [019] 50 MA PFFS 50 intangible amortization 50 Prepaid ARPU 50 Boosts Guidance 50 #cps 50 Exceed Previous 50 implied volatility Elevated 50 cents ashare 50 Silgan Holdings NASDAQ SLGN 50 beia 50 Acorda Therapeutics NASDAQ ACOR 50 Pall PLL 50 CapEx 50 Earnings Release Schedule 50 = Diluted [026] 50 Per Share Quarterly Dividend 50 Tops Views 50 ASUR regulated 50 CCPU 50 pretax goodwill impairment 50 Rockwell Automation ROK 50 Aerovironment NASDAQ AVAV 50 posts 2nd qtr 50 #.#-#.# bln eur [002] 50 Gross Margins 50 Q3 Loss Per 50 Results Release Date 50 loss allocable 50 USD#.#m [007] 50 TRMB 50 - -PRW Staff 50 NYMAGIC INC. Reports 50 NASDAQ MPWR 50 Deckers Outdoor NASDAQ DECK 50 inactive premarket 50 Beats Consensus 50 Lowers 3Q 50 Angiodynamics ANGO 50 Q1 Profit Dips 50 AXTI 50 Overall NewMarket 50 #.#x respectively 50 LCRY 50 Inspire Pharmaceuticals NASDAQ ISPH 50 GAAP EARNINGS 50 ttm 50 Per Share Dividend 50 - Adjusted [030] 50 Adjusted Operating Expenses 50 USD#.#m USD#.# [001] 50 DKK #.#bn [001] 50 Continuing Ops 50 NASDAQ GS IPAR 50 MMUS 50 Gross Margin Gross 50 = Diluted [027] 50 AMYLIN PHARMACEUTICALS 50 Revises Earnings 50 - - Non GAAP [006] 50 Pfsweb 50 de Nemours NYSE 50 Sirona Dental 50 Based Compensation Expense 50 Align Technology NASDAQ ALGN 50 BUSINESS ANALYSIS 50 Rs.#.#cr 50 Ariad Pharma 50 STRATEGIC DIRECTION AND 50 Arana Therapeutics Limited 50 PharmaNet Development 50 #x FY#E EPS [001] 50 Healthways Inc HWAY 50 FAS #R Share 50 OPANA franchise 50 Adjusted EBITDA Adjusted 50 Numerator Net income 50 Q2 F# 50 - - Net [055] 50 Winmark Corporation Announces 50 = Basic earnings [014] 50 Its beta coefficient 50 Inc BRKL 50 Full Year 50 SHARE BASIC AND DILUTED 50 noninterest expense decreased 50 = Diluted [012] 50 = Diluted [036] 50 compensation expense 50 BioFuel Reports 50 Misses Q4 50 Earnings Surge 50 EBT amounted 50 = Earnings [007] 50 Powerwave Technologies PWAV 50 BBND 50 Yet Tops Estimate 50 TAKE TWO INTERACTIVE SOFTWARE 50 AND ADJUSTED 50 FINANCIAL MEASURES 50 Rs1 #mn 50 noncash pretax charge 50 Record Second Quarter 50 EEFT 50 OIBDA 50 1Q 2Q 50 Introductory teaser rates 50 Molex MOLX 50 Summary RECONCILIATION OF 50 Jarden NYSE JAH 50 - - NET INCOME [002] 50 1H FY# [002] 50 Q2 Profit Plunges 50 Intl Rectifier 50 Profit Grows 50 Team NASDAQ TISI 50 Inc. NASDAQ COGO 50 NetFlix NASDAQ NFLX 50 Standardized distributable cash 50 Q2 50 RMB#.# RMB#.# 50 Beats Raises Guidance 50 Eclipsys NASDAQ ECLP 50 Medicis Pharma 50 nineteen analysts polled 50 ev3 Inc 50 QLogic NASDAQ QLGC 50 = DilutCommissioner Steve Tharinger 50 Annualized ROE 50 = Diluted [021] 50 #.#x EV 50 ebita 50 capital employed ROACE 50 CALCULATION 50 debt extinguishments 50 NASDAQ ISTA 50 Brush Engineered 50 QCRH 50 adjusted ebitda 50 - - [054] 50 Compass Diversified 50 Taxable equivalent 50 opg margin 50 loss NOL carryforward 50 Myriad Genetics NASDAQ MYGN 50 NASDAQ YONG 50 IBKR 50 DILUTED #,#,# #,#,# [001] 50 LBITDA 50 assuming dilution

Back to home page